Other epigenetic enzymatic activities implicated in γ-globin repression that have potential to serve as druggable targets in hemoglobinopathies include the EHMT1/2 histone methyltransferase heterodimer and the PRMT5 and PRMT1 protein arginine methyltransferases. This evidence concerns the gene PRMT5 and hemoglobinopathy.